Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Laymon

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2020
Amyloid accumulation in Down syndrome measured with amyloid loadMatthew D Zammit, Charles M Laymon, Tobey J Betthauser, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2024
Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementiaAndrea M Weinstein, Fang Fang, Chung-Chou H Chang, et al.
Frontiers in Neurology|August 21, 2019
[<sup>18</sup>F]FDG, [<sup>11</sup>C]PiB, and [<sup>18</sup>F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive DeclineDavid O Okonkwo, Ross C Puffer, Davneet S Minhas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Neuroimage. Clinical|June 28, 2021
Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Neuroimage. Clinical|December 13, 2021
White matter microstructure associations to amyloid burden in adults with Down syndromeAustin M Bazydlo, Matthew D Zammit, Minjie Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trialsJames M Mountz, Thomas E Yankeelov, Daniel L Rubin, et al.
Neurobiology of Aging|October 26, 2018
Comparison of longitudinal Aβ in nondemented elderly and Down syndromeDana L Tudorascu, Stewart J Anderson, Davneet S Minhas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
Characterizing the emergence of amyloid and tau burden in Down syndromeMatthew D Zammit, Tobey J Betthauser, Andrew K McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndromeKang-Hsien Fan, Ruyu Shi, Asma Naseer Cheema, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2020
Amyloid accumulation in Down syndrome measured with amyloid loadMatthew D Zammit, Charles M Laymon, Tobey J Betthauser, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2024
Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementiaAndrea M Weinstein, Fang Fang, Chung-Chou H Chang, et al.
Frontiers in Neurology|August 21, 2019
[<sup>18</sup>F]FDG, [<sup>11</sup>C]PiB, and [<sup>18</sup>F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive DeclineDavid O Okonkwo, Ross C Puffer, Davneet S Minhas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Neuroimage. Clinical|June 28, 2021
Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Neuroimage. Clinical|December 13, 2021
White matter microstructure associations to amyloid burden in adults with Down syndromeAustin M Bazydlo, Matthew D Zammit, Minjie Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trialsJames M Mountz, Thomas E Yankeelov, Daniel L Rubin, et al.
Neurobiology of Aging|October 26, 2018
Comparison of longitudinal Aβ in nondemented elderly and Down syndromeDana L Tudorascu, Stewart J Anderson, Davneet S Minhas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
Characterizing the emergence of amyloid and tau burden in Down syndromeMatthew D Zammit, Tobey J Betthauser, Andrew K McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndromeKang-Hsien Fan, Ruyu Shi, Asma Naseer Cheema, et al.
Pageof 8